Study seeks to improve stroke outcomes by optimizing blood glucose control

April 30, 2012, Georgia Health Sciences University

About 40 percent of ischemic stroke patients arrive at the hospital with high blood glucose levels that can worsen their brain damage, say physicians working to stop the additional loss.

Insulin, a hormone that enables cells to use glucose as energy, can help, but questions remain about the optimal way to give it, said Dr. Askiel Bruno, specialist at the Medical College of Georgia at Georgia Health Sciences University. He's a Clinical Principal Investigator on a National Institute of Neurological Disorders and Stroke-funded study that should determine whether intravenous delivery or the usual shot of insulin works best. Other Clinical Principal Investigators for the trial enrolling 1,400 participants nationally are Dr. Christiana E. Hall, University of Texas Southwestern Medical Center, and Dr. Karen C. Johnston, University of Virginia School of Medicine.

A quick finger prick to check blood glucose levels is part of the early evaluation of all in the emergency room, whether or not they are diabetic, Bruno said. It's important not only because of the association with increased damage but because the symptoms of low glucose can mimic .

"When blood glucose is high the damage is worse so lowering that glucose right away, should result in less damage and better outcomes for patients," he said.

Exactly why blood rise dramatically with a stroke is not completely understood, but it's known that stroke triggers the release of that interfere with insulin's ability to coax glucose into cells, Bruno said. A leading theory is that produced by stroke also pile on the damage.

"The body just does not respond to insulin as it should and stress hormones interfere with the response," Bruno said. In a more chronic situation, an elevated also is a major risk factor for stroke, he noted.

When acute levels are detected in stroke patients – 150 milligrams per deciliter or greater versus a healthy 100 or less – most typically get a shot of insulin. When those evels are particularly difficult to control, patients may get an intravenous dose instead, which requires closer monitoring but seem to work faster and better at getting and keeping levels safe.

The SHINE Trial directly compares stroke outcome using the two approaches to determine the most efficacious, Bruno said. Study participants will receive insulin for up to three days – when the brain's circulation should be more stable – then resume standard care. At three months, stroke recovery will be objectively assessed.

"How are you doing? That is the key question. We may find intravenous works better for some patients than others," said Bruno who led a small pilot study at Indiana University School of Medicine that showed that within four hours, intravenous insulin reduced stroke patients' 31 percent more than shots.

Stroke is the third leading cause of death in the United States, affecting nearly 800,000 Americans annually, according to the Centers for Disease Control and Prevention. About 85 percent of strokes are ischemic, which means portions of the brain aren't getting enough oxygen. The remainder result from brain bleeding. The clotbuster tPA is currently the only Food and Drug Administration-approved drug therapy for and only about 5 percent of patients receive the drug which must be given within four-and-one-half hours after the onset of symptoms.

Explore further: Type 2 diabetes: 'Intensive' versus 'conventional' blood glucose control -- no clear picture

Related Stories

Type 2 diabetes: 'Intensive' versus 'conventional' blood glucose control -- no clear picture

August 1, 2011
Research published in The Cochrane Library found that the risk of death and cardiovascular disease, such as stroke, was unchanged whether glucose control was intense or conventional. They did find, however, that when aiming ...

Use of clot busters for stroke increased from 2005 to 2009, but still low

June 2, 2011
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 — but is still low, according to research reported in Stroke: Journal of the American Heart Association.

Recommended for you

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

Obese fat becomes inflamed and scarred, which may make weight loss harder

January 12, 2018
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.